Protection Against Rabies Induced by the Non-Replicative Viral Vectors MVA and Ad5 Expressing Rabies Glycoprotein
Rabies is a zoonotic viral disease that is preventable through vaccination. Effective control strategies should follow the “One Health” concept, as targeting zoonotic pathogens at their animal source is the most effective and cost-efficient approach to protecting human health. The aim of this study...
Saved in:
| Main Authors: | Debora Patricia Garanzini, Matias Ariel Micucci, Annalies Torres Lopez, Oscar Perez, Gabriela Calamante, Maria Paula Del Medico Zajac |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/4/476 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A single dose of recombinant adenoviral vector rabies vaccine expressing two copies of glycoprotein protects mice from lethal virus challenge
by: Qunlong Li, et al.
Published: (2024-08-01) -
A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs
by: Yuan Zhang, et al.
Published: (2024-12-01) -
Management of rabies
by: J. Weyer, et al.
Published: (2019-07-01) -
ANALISIS KINERJA KEUANGAN DENGAN MENGGUNAKAN METODE MARKET VALUE ADDED (MVA) PADA PT. ELECTRONIC CITY INDONESIA TBK YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2019-2023
by: Muhammad Hariv Al Akbar Akbar, et al.
Published: (2024-12-01) -
Past, Present, and Future of Viral Vector Vaccine Platforms: A Comprehensive Review
by: Justin Tang, et al.
Published: (2025-05-01)